HeimME • NASDAQ
23andMe Holding Co.
3,35 $
Eftir lokun
3,30 $
(1,35%)-0,045
Lokað: 27. jan., 17:12:59 GMT-5 · USD · NASDAQ · Lagalegir fyrirvarar
HlutabréfSkráð hlutabréf í BandaríkinHöfuðstöðvar: Bandaríkin
Við síðustu lokun
3,50 $
Dagbil
3,33 $ - 3,60 $
Árabil
2,66 $ - 16,52 $
Markaðsvirði
80,61 m. USD
Meðalmagn
210,59 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD)sep. 2024Breyting á/á
Tekjur
44,07 m.-11,86%
Rekstrarkostnaður
81,33 m.-17,18%
Nettótekjur
-59,10 m.21,48%
Hagnaðarhlutfall
-134,1110,91%
Hagnaður á hvern hlut
EBITDA
-54,96 m.21,06%
Virkt skatthlutfall
0,07%
Heildareignir
Heildarskuldir
(USD)sep. 2024Breyting á/á
Reiðufé og skammtímafjárfestingar
126,60 m.-50,62%
Heildareignir
318,94 m.-60,19%
Heildarskuldir
217,01 m.23,31%
Eigið fé alls
101,93 m.
Útistandandi hlutabréf
26,12 m.
Eiginfjárgengi
0,89
Arðsemi eigna
-42,89%
Ávöxtun eigin fjár
-75,30%
Breyting á handbæru fé
(USD)sep. 2024Breyting á/á
Nettótekjur
-59,10 m.21,48%
Handbært fé frá rekstri
-40,93 m.28,34%
Reiðufé frá fjárfestingum
-2,70 m.2,63%
Reiðufé frá fjármögnun
260,00 þ.-83,68%
Breyting á handbæru fé
-43,37 m.25,18%
Frjálst peningaflæði
-12,82 m.59,90%
Um
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell. Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008. The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Framkvæmdastjóri
Stofnsett
apr. 2006
Vefsvæði
Starfsfólk
571
Leit
Hreinsa leit
Loka leit
Google forrit
Aðalvalmynd